Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
5.56
↓ 99% below average
Average (9y)
373.78
Historical baseline
Range
High:2831.10
Low:5.56
CAGR
-50.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | 5.56 | -99.1% |
| 2024 | 653.40 | +5355.1% |
| 2023 | 11.98 | -16.4% |
| 2022 | 14.33 | -69.4% |
| 2021 | 46.84 | -5.0% |
| 2020 | 49.29 | +214.6% |
| 2019 | 15.67 | -84.3% |
| 2018 | 99.53 | +887.0% |
| 2017 | 10.08 | -99.6% |
| 2016 | 2831.10 | - |